Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Abrams

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|February 1, 1989
Phase II trial of N-methylformamide in advanced renal cancerJ S Abrams, N Tait, H Silva, et al.
Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
Functional heterogeneity among human inducer T cell clonesD T Umetsu, H H Jabara, R H DeKruyff, et al.
The Journal of Clinical Investigation|March 1, 1992
Local cytokine production in a murine model of Escherichia coli pyelonephritisH S Rugo, P O'Hanley, A G Bishop, et al.
The New England Journal of Medicine|November 30, 1995
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06M C Christian, M S McCabe, E L Korn, et al.
Cytokine|September 1, 1992
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancersW H Gotlieb, J S Abrams, J M Watson, et al.
Blood|December 1, 1991
Lymphokine profile in bone marrow transplant recipientsL C Schneider, J H Antin, H Weinstein, et al.
American Journal of Respiratory Cell and Molecular Biology|January 1, 1991
Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF)C Vancheri, T Ohtoshi, G Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposideC P Belani, M J Egorin, J S Abrams, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer AgentsJ V Cristofaro, S S Ansher, J A Zwiebel, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|February 1, 1989
Phase II trial of N-methylformamide in advanced renal cancerJ S Abrams, N Tait, H Silva, et al.
Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
Functional heterogeneity among human inducer T cell clonesD T Umetsu, H H Jabara, R H DeKruyff, et al.
The Journal of Clinical Investigation|March 1, 1992
Local cytokine production in a murine model of Escherichia coli pyelonephritisH S Rugo, P O'Hanley, A G Bishop, et al.
The New England Journal of Medicine|November 30, 1995
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06M C Christian, M S McCabe, E L Korn, et al.
Cytokine|September 1, 1992
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancersW H Gotlieb, J S Abrams, J M Watson, et al.
Blood|December 1, 1991
Lymphokine profile in bone marrow transplant recipientsL C Schneider, J H Antin, H Weinstein, et al.
American Journal of Respiratory Cell and Molecular Biology|January 1, 1991
Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF)C Vancheri, T Ohtoshi, G Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposideC P Belani, M J Egorin, J S Abrams, et al.
Clinical Pharmacology and Therapeutics|December 17, 2016
National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer AgentsJ V Cristofaro, S S Ansher, J A Zwiebel, et al.
Pageof 13